Handelsavisen
prelaunch
Companies Healthcare PR9.BK
PR
PR9.BK SET (Bangkok) Healthcare Facilities & Services

Praram 9 Hospital PCL

$16,10
Open in Charts → Attach watcher ⌖
THB
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
12,7B THB
P/E
16,2x
EV / Rev
2,3x
Div yield
3,11 %
Op margin
14,8 %
ROE
2,7 %
Net margin
12,8 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Praram 9 Hospital PCL operates in the healthcare facilities and services industry, generating revenue primarily through hospital services and pharmaceuticals.

Business. Praram 9 Hospital PCL (PR9.BK) is a healthcare facilities and services company headquartered in Thailand. The firm operates within the Healthcare Services & Equipment sector, providing medical services and pharmaceutical-related activities. It is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding operating segments and geographic revenue mix are not disclosed.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
BUY9 analysts
9 buy0 hold0 sell
Avg 12m price target23,97

Analyst recommendations

9 analysts · consensus Buy
Buy9
Hold0
Sell0
12-month price target
23,97
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
16,2x
P/E
Analysts
Buy
9 analysts · indicative
Ownership
not yet wired
Profitability
2,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning PR9.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to PR9.BK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Praram 9 Hospital PCL (PR9.BK) is a healthcare facilities and services company headquartered in Thailand. The firm operates within the Healthcare Services & Equipment sector, providing medical services and pharmaceutical-related activities. It is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding operating segments and geographic revenue mix are not disclosed.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    Praram 9 Hospital PCL maintains a strong liquidity position, with a current ratio of 3.71 and cash and equivalents amounting to 962.05 million THB, indicating a solid ability to meet short-term obligations. The company's price-to-book ratio of 2.54 and a price-to-tangible-book ratio of 2.54 suggest that the market values the company at a premium relative to its book value.

    In terms of profitability, the company's return on equity (ROE) of 2.71% and return on assets (ROA) of 2.34% are below the industry's preferred metrics, indicating that the company is not generating returns as efficiently as its peers. The operating income of 160.38 million THB and net income of 139.10 million THB reflect a moderate level of profitability, but the high price-to-earnings ratio of 93.84 suggests that the market is paying a premium for these earnings.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which may expose it to higher concentration risk. The company's free cash flow is negative at -52.33 million THB, indicating that it is not generating sufficient cash from operations to cover its capital expenditures of -107.55 million THB.

    Looking ahead, the company is expected to see a growth in revenue, with a positive outlook for the current fiscal year. The mean price target of 23.97 THB and median price target of 23.00 THB suggest that analysts have a positive outlook on the company's future performance. The company's liquidity risk is low, and there are no immediate filing-based liquidity or dilution flags, indicating a stable financial position.

    Recent events and filings do not indicate any significant changes in the company's operations or financial status. The company's capital structure is characterized by a low debt-to-equity ratio of 0.0, suggesting that it is primarily financed through equity. The company's market cap of 13.05 billion THB and a market price of 16.6 THB per share indicate a relatively high valuation in the market.

    Key takeaways
    • Praram 9 Hospital PCL has a strong liquidity position with a current ratio of 3.71 and significant cash reserves.
    • The company's profitability metrics, such as ROE and ROA, are below industry standards, indicating inefficiencies in generating returns.
    • The company's revenue is concentrated in a single segment, which may increase its exposure to market risks.
    • Analysts have a positive outlook on the company, with a mean price target of 23.97 THB and a median price target of 23.00 THB.
    • The company's capital structure is primarily equity-based, with a low debt-to-equity ratio of 0.0.
    • "margin_outlook_rationale": "The company's operating margin is expected to remain stable due to consistent revenue and controlled operating expenses.",

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Revenue grew 15.2% CAGR over four years, demonstrating strong top-line expansion momentum for the hospital.

    Net income surged 34.8% CAGR over four years, significantly outpacing revenue growth and indicating operating leverage.

    Analysts project 48.9% upside to a mean price target of 23.97 THB, signaling strong market confidence.

    BEAR CASE · 2

    Return on equity of 2.7% falls below the healthcare cohort median of 4.6%, indicating inefficient capital utilization.

    Long-term debt increased to 15.98 million THB in FY2026, nearly tripling from the prior year's level.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-05-13
    Q1 2026 · Quarter highlights

    Revenue THB 1.29B, +3,7% YoY; Operating income −6,9% YoY.

    RevenueTHB 1.29B+3,7 % YoY
    Operating incomeTHB 222.5M−6,9 % YoY
    Net incomeTHB 184.5M−8,0 % YoY
    Free cash flowTHB 181.3M+11,0 % YoY
    EPS
    Operating cash flowTHB 168.9M−44,2 % YoY
    Financials
    Income statement
    RevenueTHB 1.29B
    Gross profitTHB 457.0M
    Operating incomeTHB 222.5M
    Net incomeTHB 184.5M
    Margins
    Gross margin35.5%
    Operating margin17.3%
    Net margin14.3%
    FCF margin14.1%
    Balance sheet
    Total assetsTHB 7.28B
    Total liabilitiesTHB 1.22B
    Total equityTHB 6.06B
    Cash & equivalentsTHB 1.00B
    Long-term debtTHB 15.3M
    Cash flow
    Operating cash flowTHB 168.9M
    CapEx-THB 86.6M
    Free cash flowTHB 181.3M
    SBC
    P&L flow · revenue → net income
    Revenue THB 1.29BOperating costs THB 1.07BTax THB 38.0MNet income THB 184.5M
    Highlights
    • Revenue THB 1.29B, +3,7% YoY
    • Operating income −6,9% YoY
    • Net income −8,0% YoY
    • Free cash flow +11,0% YoY
    • Net margin 14.3%

    Valuation TTM

    Market price
    $16,10
    Market cap
    $13.05B
    Enterprise value
    $12.10B
    P/E
    16.2x
    Non-GAAP P/E
    EV / Revenue
    2.3x
    EV / Op income
    12.8x
    EV / OCF
    25.4x
    P / B
    2.5x
    P / Tangible book
    2.5x
    Tangible book
    $5.14B
    Net cash
    $954.7M
    Current ratio
    3.7
    Debt / equity
    0.0
    ROA
    2.3%
    ROE
    2.7%
    Cash conversion
    343.0%
    CapEx / revenue
    -9.9%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    1,09
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    9
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-23 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate1,09
    Revenueno estimateno estimate5,5B THB
    Operating incomeno estimateno estimate999,5M THB
    Full-year consensus mean (period as reported by source) · consensus in THB. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution9 analysts
    Strong buy3
    Buy6
    Hold0
    Sell0
    Strong sell0
    12-month price target$23,97 · Median $23,00
    Low $20,00High $32,00
    Operating income · consensus999,5M THB
    EPS surprise
    −3,5 %
    reported vs consensus · miss
    Revenue surprise
    −3,5 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$20,00
    Mean$23,97
    Median$23,00
    High$32,00
    Spot$16,10
    +48.9 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin14,8 %Above median
    Net Margin12,8 %Above P75
    ROE2,7 %Below median
    Capex / Rev-9,9 %Below median
    D/E0,00Above P75
    Cash Conv3,43Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • Praram 9 Hospital PCL Market data — financials · 2026-05-29
    • Praram 9 Hospital PCL Market data — analyst estimates · 2026-05-29
    • Praram 9 Hospital PCL Market data — ESG · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    PR9.BKCanonical
    SET (Bangkok) · THB

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-05-13 06:21 UTCEARNINGSQuarterly results — Q1 2026 Revenue THB 1.29B · Net THB 184.5M
    2026-02-18 06:36 UTCEARNINGSQuarterly results — Q4 2025 Revenue THB 1.40B · Net THB 216.9M
    2026-02-18 06:36 UTCEARNINGSAnnual results — FY 2026 Revenue THB 5.29B · Net THB 822.7M
    2025-11-07 16:23 UTCEARNINGSQuarterly results — Q3 2025 Revenue THB 1.37B · Net THB 223.3M
    2025-08-15 06:24 UTCEARNINGSQuarterly results — Q2 2025 Revenue THB 1.28B · Net THB 182.0M
    2025-05-15 20:52 UTCEARNINGSQuarterly results — Q1 2025 Revenue THB 1.24B · Net THB 200.5M
    2025-02-19 06:33 UTCEARNINGSQuarterly results — Q4 2024 Revenue THB 1.26B · Net THB 206.6M
    2025-02-19 06:33 UTCEARNINGSAnnual results — FY 2025 Revenue THB 4.65B · Net THB 712.7M
    2024-11-11 06:52 UTCEARNINGSQuarterly results — Q3 2024 Revenue THB 1.23B · Net THB 208.0M
    2024-08-08 05:59 UTCEARNINGSQuarterly results — Q2 2024 Revenue THB 1.09B · Net THB 139.1M
    2024-02-20 07:00 UTCEARNINGSAnnual results — FY 2024 Revenue THB 4.22B · Net THB 557.9M
    2023-02-22 06:06 UTCEARNINGSAnnual results — FY 2023 Revenue THB 4.12B · Net THB 567.6M
    2022-02-17 06:57 UTCEARNINGSAnnual results — FY 2022 Revenue THB 3.00B · Net THB 249.2M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage